The Quandary of DNA-Based Treatment Assessment in De Novo Metastatic Prostate Cancer in the Era of Precision Oncology

Guidelines for genetic testing have been established for multiple tumor types, frequently indicating the most confident molecularly targeted treatment options. However, considering the often-complex presentation of individual cancer patients, in addition to the combinatorial complexity and inherent...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakken, Sigve, Lilleby, Wolfgang, Switlyk, Marta D., Knudsen, Karen E., Lilleby, Oscar, Zhao, Sen, Kaveh, Fatemeh, Ekstrøm, Per O., Urbanucci, Alfonso, Hovig, Eivind
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143497/
https://www.ncbi.nlm.nih.gov/pubmed/33922147
http://dx.doi.org/10.3390/jpm11050330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143497/
https://www.ncbi.nlm.nih.gov/pubmed/33922147
http://dx.doi.org/10.3390/jpm11050330

Ejemplares similares